{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T05:05:58Z","timestamp":1779512758106,"version":"3.53.1"},"reference-count":94,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Computers in Biology and Medicine"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/j.compbiomed.2025.110862","type":"journal-article","created":{"date-parts":[[2025,8,2]],"date-time":"2025-08-02T07:47:52Z","timestamp":1754120872000},"page":"110862","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"PB","title":["Interpretable bioinformatics approaches for pheochromocytoma bioactivity and protein interaction analysis"],"prefix":"10.1016","volume":"196","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6091-9110","authenticated-orcid":false,"given":"\u0130lhan","family":"Uysal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.compbiomed.2025.110862_bib1","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1159\/000529319","article-title":"Genetic study in pheochromocytoma: is it possible to stratify the risk of hereditary pheochromocytoma?","volume":"113","author":"Araujo\u2010Castro","year":"2023","journal-title":"Neuroendocrinology"},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110862_bib2","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00268-021-06393-w","article-title":"Clinical, biochemical, tumoural and mutation profile of VHL\u2010 and MEN2A\u2010associated pheochromocytoma: a comparative study","volume":"46","author":"Dhanda","year":"2021","journal-title":"World J. Surg."},{"issue":"9","key":"10.1016\/j.compbiomed.2025.110862_bib3","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/PAS.0000000000001768","article-title":"Pheochromocytoma","volume":"45","author":"Z","year":"2021","journal-title":"Am. J. Surg. Pathol."},{"key":"10.1016\/j.compbiomed.2025.110862_bib4","article-title":"Computed tomography-based machine learning differentiates adrenal pheochromocytoma from lipid-poor adenoma","volume":"13","author":"Liu","year":"2022","journal-title":"Front. Endocrinol."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110862_bib5","doi-asserted-by":"crossref","DOI":"10.1186\/s12880-023-01106-2","article-title":"Machine learning for differentiation of lipid-poor adrenal adenoma and subclinical pheochromocytoma based on multiphase CT imaging radiomics","volume":"23","author":"Xiao","year":"2023","journal-title":"BMC Med. Imag."},{"issue":"7","key":"10.1016\/j.compbiomed.2025.110862_bib6","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1210\/clinem\/dgad024","article-title":"Nomogram for predicting intraoperative hemodynamic instability in patients with normotensive pheochromocytoma","volume":"108","author":"Liu","year":"2023","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"6","key":"10.1016\/j.compbiomed.2025.110862_bib7","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.3390\/biomedicines10061310","article-title":"From SGAP-model to SGAP-score: a simplified predictive tool for post-surgical recurrence of pheochromocytoma","volume":"10","author":"Parasiliti\u2010Caprino","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.compbiomed.2025.110862_bib8","article-title":"ASO visual abstract: machine learning model for predicting pheochromocytomas\/paragangliomas surgery difficulty\u2014a retrospective cohort study","author":"Zhang","year":"2025","journal-title":"Ann. Surg Oncol."},{"issue":"9","key":"10.1016\/j.compbiomed.2025.110862_bib9","first-page":"e551","article-title":"Prediction of metastatic pheochromocytoma and paraganglioma: a machine learning modelling study using data from a cross-sectional cohort, Lancet digit","volume":"5","author":"Pamporaki","year":"2023","journal-title":"Health"},{"issue":"11","key":"10.1016\/j.compbiomed.2025.110862_bib10","doi-asserted-by":"crossref","DOI":"10.1007\/s12032-024-02532-0","article-title":"Personalized oncology in pheochromocytomas and paragangliomas: integrating genetic analysis with machine learning","volume":"41","author":"Abida","year":"2024","journal-title":"Med. Oncol."},{"issue":"19","key":"10.1016\/j.compbiomed.2025.110862_bib11","doi-asserted-by":"crossref","first-page":"3577","DOI":"10.7150\/jca.26356","article-title":"Adrenal incidentaloma: machine learning-based quantitative texture analysis of unenhanced CT can effectively differentiate sPHEO from lipid-poor adrenal adenoma","volume":"9","author":"Yi","year":"2018","journal-title":"J. Cancer"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110862_bib12","doi-asserted-by":"crossref","DOI":"10.1186\/s13244-025-01952-4","article-title":"CT-based radiomics deep learning signatures for non-invasive prediction of metastatic potential in pheochromocytoma and paraganglioma: a multicohort study","volume":"16","author":"Zhou","year":"2025","journal-title":"Insights Imaging"},{"issue":"7","key":"10.1016\/j.compbiomed.2025.110862_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0022284","article-title":"The action mechanism of the MYC inhibitor termed Omomyc may give clues on how to target MYC for cancer therapy","volume":"6","author":"Savino","year":"2011","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110862_bib14","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.cell.2012.08.026","article-title":"Transcriptional amplification in tumor cells with elevated c-Myc","volume":"151","author":"Lin","year":"2012","journal-title":"Cell"},{"issue":"25","key":"10.1016\/j.compbiomed.2025.110862_bib15","doi-asserted-by":"crossref","first-page":"10258","DOI":"10.1073\/pnas.1222404110","article-title":"MYC inhibition induces metabolic changes leading to accumulation of lipid droplets in tumor cells","volume":"110","author":"Zirath","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"2","key":"10.1016\/j.compbiomed.2025.110862_bib16","doi-asserted-by":"crossref","first-page":"278","DOI":"10.7150\/jca.17302","article-title":"Network biomarkers constructed from gene expression and protein-protein interaction data for accurate prediction of leukemia","volume":"8","author":"Yuan","year":"2017","journal-title":"J. Cancer"},{"key":"10.1016\/j.compbiomed.2025.110862_bib17","series-title":"Handbook of Genetic Programming Applications","first-page":"183","article-title":"Genetic programming for machine learning","author":"Petrowski","year":"2017"},{"key":"10.1016\/j.compbiomed.2025.110862_bib18","article-title":"Genetic programming for evolving similarity functions tailored to clustering algorithms","author":"Andersen","year":"2021","journal-title":"Proc. IEEE Congr. Evol. Comput."},{"issue":"4","key":"10.1016\/j.compbiomed.2025.110862_bib19","doi-asserted-by":"crossref","first-page":"215","DOI":"10.14311\/NNW.2022.32.013","article-title":"Two-layer genetic programming","volume":"32","author":"Merta","year":"2022","journal-title":"Neural Netw. World"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110862_bib20","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ccell.2014.11.014","article-title":"mTORC1 activation blocks BRAFV600E-induced growth arrest but is insufficient for melanoma formation","volume":"27","author":"Damsky","year":"2015","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.compbiomed.2025.110862_bib21","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1158\/1541-7786.MCR-15-0418","article-title":"Expression of ANRIL\u2013polycomb complexes\u2013CDKN2A\/B\/ARF genes in breast tumors: identification of a two-gene (EZH2\/CBX7) signature with independent prognostic value","volume":"14","author":"Meseure","year":"2016","journal-title":"Mol. Cancer Res."},{"issue":"6","key":"10.1016\/j.compbiomed.2025.110862_bib22","first-page":"483","article-title":"TGF\u2010\u03b2RII\/EP300\/SMAD4 cascade signaling pathway promotes invasion and glycolysis in oral squamous cell carcinoma, J. Oral Pathol","volume":"52","author":"Zhang","year":"2023","journal-title":"Med"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110862_bib23","doi-asserted-by":"crossref","first-page":"507","DOI":"10.21037\/jtd-23-1017","article-title":"Prognosis of immunotherapy for non-small cell lung cancer with CDKN2A loss of function","volume":"16","author":"Zhao","year":"2024","journal-title":"J. Thorac. Dis."},{"key":"10.1016\/j.compbiomed.2025.110862_bib24","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.bcp.2019.03.009","article-title":"Oncogenic EP300 can be targeted with inhibitors of aldo-keto reductases","volume":"163","author":"Mahmud","year":"2019","journal-title":"Biochem. Pharmacol."},{"issue":"25","key":"10.1016\/j.compbiomed.2025.110862_bib25","first-page":"2579","article-title":"SETD1A\u2010mediated H3K4me3 methylation upregulates lncRNA HOXC\u2010AS3 and the binding of HOXC\u2010AS3 to EP300 and increases EP300 stability to suppress the ferroptosis of NSCLC cells, Thorac","volume":"14","author":"Shi","year":"2023","journal-title":"Cancer"},{"issue":"8","key":"10.1016\/j.compbiomed.2025.110862_bib26","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.3390\/biomedicines11082254","article-title":"Cyclin dependent kinase inhibitor 2A genetic and epigenetic alterations interfere with several immune components and predict poor clinical outcome","volume":"11","author":"Soltan","year":"2023","journal-title":"Biomedicines"},{"issue":"26","key":"10.1016\/j.compbiomed.2025.110862_bib27","doi-asserted-by":"crossref","first-page":"3454","DOI":"10.1038\/onc.2015.405","article-title":"Sleeping beauty transposon screen identifies signaling modules that cooperate with STAT5 activation to induce B-cell acute lymphoblastic leukemia","volume":"35","author":"Heltemes-Harris","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/j.compbiomed.2025.110862_bib28","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.80854","article-title":"MLL3 regulates the CDKN2A tumor suppressor locus in liver cancer","volume":"12","author":"Zhu","year":"2023","journal-title":"eLife"},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110862_bib29","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.jbi.2010.03.009","article-title":"Protein interaction network underpins concordant prognosis among heterogeneous breast cancer signatures","volume":"43","author":"Chen","year":"2010","journal-title":"J. Biomed. Inf."},{"issue":"Suppl 3","key":"10.1016\/j.compbiomed.2025.110862_bib30","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1186\/1471-2164-11-S3-S5","article-title":"A comparative study of cancer proteins in the human protein\u2013protein interaction network","volume":"11","author":"Sun","year":"2010","journal-title":"BMC Genom."},{"key":"10.1016\/j.compbiomed.2025.110862_bib31","article-title":"Exploring genes of rectal cancer for new treatments based on protein interaction network","author":"Teng","year":"2016","journal-title":"bioRxiv"},{"issue":"4","key":"10.1016\/j.compbiomed.2025.110862_bib32","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1039\/C5MB00399G","article-title":"SNRFCB: sub-network based random forest classifier for predicting chemotherapy benefit on survival for cancer treatment","volume":"12","author":"Shi","year":"2016","journal-title":"Mol. Biosyst."},{"issue":"11","key":"10.1016\/j.compbiomed.2025.110862_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187091","article-title":"DiffSLC: a graph centrality method to detect essential proteins of a protein-protein interaction network","volume":"12","author":"Mistry","year":"2017","journal-title":"PLoS One"},{"issue":"13","key":"10.1016\/j.compbiomed.2025.110862_bib34","doi-asserted-by":"crossref","first-page":"5325","DOI":"10.7314\/APJCP.2014.15.13.5325","article-title":"Construction of a protein-protein interaction network for chronic myelocytic leukemia and pathway prediction of molecular complexes","volume":"15","author":"Zhou","year":"2014","journal-title":"Asian Pac. J. Cancer Prev. APJCP"},{"issue":"6","key":"10.1016\/j.compbiomed.2025.110862_bib35","doi-asserted-by":"crossref","DOI":"10.1103\/PhysRevE.83.066118","article-title":"Parameterized centrality metric for network analysis","volume":"83","author":"Ghosh","year":"2011","journal-title":"Phys. Rev. E"},{"issue":"8","key":"10.1016\/j.compbiomed.2025.110862_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0023016","article-title":"Dominating biological networks","volume":"6","author":"Milenkovi\u0107","year":"2011","journal-title":"PLoS One"},{"issue":"Suppl 3","key":"10.1016\/j.compbiomed.2025.110862_bib37","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1186\/1752-0509-5-S3-S10","article-title":"Integration of breast cancer gene signatures based on graph centrality","volume":"5","author":"Wang","year":"2011","journal-title":"BMC Syst. Biol."},{"issue":"13","key":"10.1016\/j.compbiomed.2025.110862_bib38","doi-asserted-by":"crossref","first-page":"3119","DOI":"10.1158\/0008-5472.CAN-11-3891","article-title":"MAX and MYC: a heritable breakup","volume":"72","author":"Casc\u00f3n","year":"2012","journal-title":"Cancer Res."},{"issue":"5","key":"10.1016\/j.compbiomed.2025.110862_bib39","doi-asserted-by":"crossref","DOI":"10.3892\/ijo.2023.5568","article-title":"RYBP contributes to improved prognosis in colorectal cancer via regulation of cell cycle, apoptosis and oxaliplatin sensitivity","volume":"63","author":"Morinaka","year":"2023","journal-title":"Int. J. Oncol."},{"issue":"2","key":"10.1016\/j.compbiomed.2025.110862_bib40","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1021\/acsomega.3c05822","article-title":"Unraveling the behavior of intrinsically disordered protein c-Myc: a study utilizing Gaussian-accelerated molecular dynamics","volume":"9","author":"Gunasinghe","year":"2023","journal-title":"ACS Omega"},{"issue":"34","key":"10.1016\/j.compbiomed.2025.110862_bib41","doi-asserted-by":"crossref","first-page":"12556","DOI":"10.1073\/pnas.1319488111","article-title":"Inhibitor of MYC identified in a Kr\u00f6hnke pyridine library","volume":"111","author":"Hart","year":"2014","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"22","key":"10.1016\/j.compbiomed.2025.110862_bib42","doi-asserted-by":"crossref","DOI":"10.1128\/MCB.00248-19","article-title":"Omomyc reveals new mechanisms to inhibit the MYC oncogene","volume":"39","author":"Demma","year":"2019","journal-title":"Mol. Cell Biol."},{"issue":"5","key":"10.1016\/j.compbiomed.2025.110862_bib43","doi-asserted-by":"crossref","first-page":"472","DOI":"10.32598\/JQUMS.24.5.10","article-title":"The role of mammalian target of rapamycin signaling pathway in central nervous system cancers: a review","volume":"24","author":"Serej","year":"2020","journal-title":"J. Qazvin Univ. Med. Sci."},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110862_bib44","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/1752-0509-6-92","article-title":"HINT: high-quality protein interactomes and their applications in understanding human disease","volume":"6","author":"Das","year":"2012","journal-title":"BMC Syst. Biol."},{"issue":"5","key":"10.1016\/j.compbiomed.2025.110862_bib45","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1073\/pnas.1211604110","article-title":"RNF2\/RING1B negatively regulates p53 expression in selective cancer cell types to promote tumor development","volume":"110","author":"Su","year":"2013","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110862_bib46","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1038\/srep00900","article-title":"Network rewiring is an important mechanism of gene essentiality change","volume":"2","author":"Kim","year":"2012","journal-title":"Sci. Rep."},{"key":"10.1016\/j.compbiomed.2025.110862_bib47","doi-asserted-by":"crossref","first-page":"112028","DOI":"10.1109\/ACCESS.2022.3216416","article-title":"Centrality combination method based on feature selection for protein interaction networks","volume":"10","author":"Wang","year":"2022","journal-title":"IEEE Access"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110862_bib48","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1093\/jnci\/djab158","article-title":"Germline SUCLG2 variants in patients with pheochromocytoma and paraganglioma","volume":"114","author":"Vanova","year":"2021","journal-title":"JNCI J. Natl. Cancer Inst."},{"issue":"4","key":"10.1016\/j.compbiomed.2025.110862_bib49","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1038\/nrc1589","article-title":"Mechanisms of B-cell lymphoma pathogenesis","volume":"5","author":"K\u00fcppers","year":"2005","journal-title":"Nat. Rev. Cancer"},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110862_bib50","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.chom.2014.02.011","article-title":"Human viral oncogenesis: a cancer hallmarks analysis","volume":"15","author":"Mesri","year":"2014","journal-title":"Cell Host Microbe"},{"issue":"11","key":"10.1016\/j.compbiomed.2025.110862_bib51","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/nrc1997","article-title":"MicroRNA signatures in human cancers","volume":"6","author":"Calin","year":"2006","journal-title":"Nat. Rev. Cancer"},{"issue":"5","key":"10.1016\/j.compbiomed.2025.110862_bib52","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1016\/j.cell.2011.02.013","article-title":"Hallmarks of cancer: the next generation","volume":"144","author":"Hanahan","year":"2011","journal-title":"Cell"},{"key":"10.1016\/j.compbiomed.2025.110862_bib53","first-page":"52","article-title":"Thyroid hormones and cancer: clinical studies of hypothyroidism in oncology","volume":"3","author":"Hercbergs","year":"2018","journal-title":"Curr. Opin. Endocr. Metab. Res."},{"issue":"6127","key":"10.1016\/j.compbiomed.2025.110862_bib54","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1126\/science.1235122","article-title":"Cancer genome landscapes","volume":"339","author":"Vogelstein","year":"2013","journal-title":"Science"},{"issue":"5","key":"10.1016\/j.compbiomed.2025.110862_bib55","first-page":"615","article-title":"Mitogen-activated protein (MAP) kinase pathways: regulation and physiological functions","volume":"21","author":"Pearson","year":"2000","journal-title":"Endocr. Rev."},{"key":"10.1016\/j.compbiomed.2025.110862_bib56","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1146\/annurev-physiol-030212-183653","article-title":"Aging, cellular senescence, and cancer","volume":"75","author":"Campisi","year":"2013","journal-title":"Annu. Rev. Physiol."},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110862_bib57","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1152\/physrev.00002.2013","article-title":"Deubiquitylases from genes to organism","volume":"93","author":"Clague","year":"2013","journal-title":"Physiol. Rev."},{"issue":"9","key":"10.1016\/j.compbiomed.2025.110862_bib58","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.molmed.2007.07.004","article-title":"Chromatin remodeling and cancer, Part II: ATP-dependent chromatin remodeling","volume":"13","author":"Wang","year":"2007","journal-title":"Trends Mol. Med."},{"issue":"7092","key":"10.1016\/j.compbiomed.2025.110862_bib59","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nature04870","article-title":"Nuclear factor-\u03baB in cancer development and progression","volume":"441","author":"Karin","year":"2006","journal-title":"Nature"},{"issue":"13","key":"10.1016\/j.compbiomed.2025.110862_bib60","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1101\/gad.11.13.1640","article-title":"Yeast Gcn5 functions in two multisubunit complexes to acetylate nucleosomal histones: characterization of an Ada complex and the SAGA (Spt\/Ada) complex","volume":"11","author":"Grant","year":"1997","journal-title":"Genes Dev."},{"issue":"7015","key":"10.1016\/j.compbiomed.2025.110862_bib61","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/nature03094","article-title":"G1 cell-cycle control and cancer","volume":"432","author":"Massagu\u00e9","year":"2004","journal-title":"Nature"},{"issue":"5293","key":"10.1016\/j.compbiomed.2025.110862_bib62","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1126\/science.274.5293.1672","article-title":"Cancer cell cycles","volume":"274","author":"Sherr","year":"1996","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110862_bib63","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/S0092-8674(00)81871-1","article-title":"p53, the cellular gatekeeper for growth and division","volume":"88","author":"Levine","year":"1997","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110862_bib64","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.cell.2012.03.003","article-title":"MYC on the path to cancer","volume":"149","author":"Dang","year":"2012","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110862_bib65","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1146\/annurev.cellbio.16.1.653","article-title":"The Myc\/Max\/Mad network and the transcriptional control of cell behavior","volume":"16","author":"Grandori","year":"2000","journal-title":"Annu. Rev. Cell Dev. Biol."},{"issue":"6","key":"10.1016\/j.compbiomed.2025.110862_bib66","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/j.cell.2005.04.031","article-title":"Physical association and coordinate function of the H3 K4 methyltransferase MLL1 and the H4 K16 acetyltransferase MOF","volume":"121","author":"Dou","year":"2005","journal-title":"Cell"},{"key":"10.1016\/j.compbiomed.2025.110862_bib67","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.pharmthera.2014.11.002","article-title":"Deubiquitinase inhibition as a cancer therapeutic strategy","volume":"147","author":"D'Arcy","year":"2015","journal-title":"Pharmacol. Ther."},{"issue":"4","key":"10.1016\/j.compbiomed.2025.110862_bib68","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/j.cell.2016.12.013","article-title":"Transcriptional addiction in cancer","volume":"168","author":"Bradner","year":"2017","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.compbiomed.2025.110862_bib69","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.cell.2011.08.017","article-title":"BET bromodomain inhibition as a therapeutic strategy to target c-Myc","volume":"146","author":"Delmore","year":"2011","journal-title":"Cell"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110862_bib70","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/nrd.2017.152","article-title":"Deubiquitylating enzymes and drug discovery: emerging opportunities","volume":"17","author":"Harrigan","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"issue":"23","key":"10.1016\/j.compbiomed.2025.110862_bib85","doi-asserted-by":"crossref","first-page":"10220","DOI":"10.1128\/MCB.25.23.10220-10234.2005","article-title":"Dual regulation of c-Myc by p300 via acetylation-dependent control of Myc protein turnover and coactivation of Myc-induced transcription","volume":"25","author":"Faiola","year":"2005","journal-title":"Mol. Cell Biol."},{"issue":"4","key":"10.1016\/j.compbiomed.2025.110862_bib87","doi-asserted-by":"crossref","DOI":"10.1038\/cddis.2013.107","article-title":"TTC5 is required to prevent apoptosis of acute myeloid leukemia stem cells","volume":"4","author":"Lynch","year":"2013","journal-title":"Cell Death Dis."},{"issue":"4998","key":"10.1016\/j.compbiomed.2025.110862_bib79","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1126\/science.2006410","article-title":"Max: a helix-loop-helix zipper protein that forms a sequence-specific DNA-binding complex with Myc","volume":"251","author":"Blackwood","year":"1991","journal-title":"Science"},{"issue":"24","key":"10.1016\/j.compbiomed.2025.110862_bib86","doi-asserted-by":"crossref","first-page":"3749","DOI":"10.1038\/sj.onc.1206439","article-title":"BRCA1 shifts p53-mediated cellular outcomes towards irreversible growth arrest","volume":"22","author":"Ongusaha","year":"2003","journal-title":"Oncogene"},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110862_bib88","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.molonc.2013.12.018","article-title":"TP53 mutation\u2010correlated genes predict the risk of tumor relapse and identify MPS1 as a potential therapeutic kinase in TP53\u2010mutated breast cancers","volume":"8","author":"Gy\u0151rffy","year":"2014","journal-title":"Mol. Oncol."},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110862_bib89","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1002\/dvdy.24481","article-title":"Hypoxia and hyperoxia differentially control proliferation of rat neural crest stem cells via distinct regulatory pathways of the HIF1\u03b1\u2013CXCR4 and TP53\u2013TPM1 proteins","volume":"246","author":"Chen","year":"2017","journal-title":"Dev. Dyn."},{"issue":"17","key":"10.1016\/j.compbiomed.2025.110862_bib75","doi-asserted-by":"crossref","first-page":"5001","DOI":"10.1093\/emboj\/17.17.5001","article-title":"The alternative product from the human CDKN2A locus, p14ARF, participates in a regulatory feedback loop with p53 and MDM2","volume":"17","author":"Stott","year":"1998","journal-title":"EMBO J."},{"issue":"13","key":"10.1016\/j.compbiomed.2025.110862_bib90","doi-asserted-by":"crossref","first-page":"6070","DOI":"10.1093\/nar\/gkw523","article-title":"Integration of TP53, DREAM, MMB-FOXM1 and RB-E2F target gene analyses identifies cell cycle gene regulatory networks","volume":"44","author":"Fischer","year":"2016","journal-title":"Nucleic Acids Res."},{"issue":"12","key":"10.1016\/j.compbiomed.2025.110862_bib77","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0225784","article-title":"Formation of a structurally-stable conformation by the intrinsically disordered MYC:TRRAP complex","volume":"14","author":"Feris","year":"2019","journal-title":"PLoS One"},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110862_bib78","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0092-8674(00)81479-8","article-title":"The novel ATM-related protein TRRAP is an essential cofactor for the c-Myc and E2F oncoproteins","volume":"94","author":"McMahon","year":"1998","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.compbiomed.2025.110862_bib73","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0092-8674(00)80521-8","article-title":"Activation of p53 sequence-specific DNA binding by acetylation of the p53 C-terminal domain","volume":"90","author":"Gu","year":"1997","journal-title":"Cell"},{"issue":"6","key":"10.1016\/j.compbiomed.2025.110862_bib74","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/sj.cdd.4401925","article-title":"The complexity of p53 stabilization and activation","volume":"13","author":"Lavin","year":"2006","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.compbiomed.2025.110862_bib91","article-title":"A cancer-specific antigen drives histone acetylation by stabilizing the acetyltransferases","author":"Fu","year":"2025","journal-title":"bioRxiv"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110862_bib92","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-023-04305-1","article-title":"Aberrant KAT2A accumulations render TRIM22-low melanoma sensitive to NOTCH1 inhibitors via epigenetic reprogramming","volume":"21","author":"Gu","year":"2023","journal-title":"J. Transl. Med."},{"issue":"3","key":"10.1016\/j.compbiomed.2025.110862_bib93","doi-asserted-by":"crossref","DOI":"10.1128\/mBio.01190-20","article-title":"Expression of the long noncoding RNA DINO in human papillomavirus-positive cervical cancer cells reactivates the dormant TP53 tumor suppressor through ATM\/CHK2 signaling","volume":"11","author":"Sharma","year":"2020","journal-title":"mBio"},{"issue":"1","key":"10.1016\/j.compbiomed.2025.110862_bib94","doi-asserted-by":"crossref","DOI":"10.1186\/s12935-024-03414-1","article-title":"NFIC mediates m6A mRNA methylation to orchestrate transcriptional and post-transcriptional regulation to repress malignant phenotype of non-small cell lung cancer cells","volume":"24","author":"Shi","year":"2024","journal-title":"Cancer Cell Int."},{"issue":"6810","key":"10.1016\/j.compbiomed.2025.110862_bib71","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/35042675","article-title":"Surfing the p53 network","volume":"408","author":"Vogelstein","year":"2000","journal-title":"Nature"},{"issue":"2","key":"10.1016\/j.compbiomed.2025.110862_bib72","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ccell.2017.01.001","article-title":"Comprehensive molecular characterization of pheochromocytoma and paraganglioma","volume":"31","author":"Fishbein","year":"2017","journal-title":"Cancer Cell"},{"issue":"7","key":"10.1016\/j.compbiomed.2025.110862_bib76","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1038\/nrc3960","article-title":"Forging a signature of in vivo senescence","volume":"15","author":"Sharpless","year":"2015","journal-title":"Nat. Rev. Cancer"},{"issue":"6","key":"10.1016\/j.compbiomed.2025.110862_bib80","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3390\/genes8060151","article-title":"MYC deregulation in primary human cancers","volume":"8","author":"Kalkat","year":"2017","journal-title":"Genes"},{"issue":"9","key":"10.1016\/j.compbiomed.2025.110862_bib81","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/j.bbagrm.2014.07.011","article-title":"The role of H3K4me3 and H3K9\/14ac in the induction by dexamethasone of Per1 and Sgk1, two glucocorticoid early response genes that mediate the effects of acute stress in mammals","volume":"1839","author":"Xydous","year":"2014","journal-title":"Biochim. Biophys. Acta Gene Regul. Mech."},{"issue":"12","key":"10.1016\/j.compbiomed.2025.110862_bib82","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1021\/cb2003187","article-title":"A small molecule mimicking a phosphatidylinositol (4,5)-bisphosphate binding pleckstrin homology domain","volume":"6","author":"Mak","year":"2011","journal-title":"ACS Chem. Biol."},{"issue":"2","key":"10.1016\/j.compbiomed.2025.110862_bib83","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1039\/C7SC02664A","article-title":"MoleculeNet: a benchmark for molecular machine learning","volume":"9","author":"Wu","year":"2018","journal-title":"Chem. Sci."},{"issue":"0","key":"10.1016\/j.compbiomed.2025.110862_bib84","doi-asserted-by":"crossref","DOI":"10.21608\/mjeer.2020.20533.1000","article-title":"Machine learning model for cancer diagnosis based on RNA-seq microarray","volume":"0","author":"Torkey","year":"2020","journal-title":"Menoufia J. Electron. Eng. Res."}],"container-title":["Computers in Biology and Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482525012132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010482525012132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,23]],"date-time":"2026-05-23T04:19:30Z","timestamp":1779509970000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010482525012132"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9]]},"references-count":94,"alternative-id":["S0010482525012132"],"URL":"https:\/\/doi.org\/10.1016\/j.compbiomed.2025.110862","relation":{},"ISSN":["0010-4825"],"issn-type":[{"value":"0010-4825","type":"print"}],"subject":[],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interpretable bioinformatics approaches for pheochromocytoma bioactivity and protein interaction analysis","name":"articletitle","label":"Article Title"},{"value":"Computers in Biology and Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.compbiomed.2025.110862","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110862"}}